nodes	percent_of_prediction	percent_of_DWPC	metapath
Amisulpride—Embolism venous—Prednisolone—ankylosing spondylitis	0.023	0.023	CcSEcCtD
Amisulpride—Drug withdrawal syndrome—Methylprednisolone—ankylosing spondylitis	0.0217	0.0217	CcSEcCtD
Amisulpride—Embolism venous—Triamcinolone—ankylosing spondylitis	0.0211	0.0211	CcSEcCtD
Amisulpride—Embolism venous—Methylprednisolone—ankylosing spondylitis	0.0211	0.0211	CcSEcCtD
Amisulpride—Drug withdrawal syndrome—Betamethasone—ankylosing spondylitis	0.0197	0.0197	CcSEcCtD
Amisulpride—Drug withdrawal syndrome—Dexamethasone—ankylosing spondylitis	0.0197	0.0197	CcSEcCtD
Amisulpride—Embolism venous—Dexamethasone—ankylosing spondylitis	0.0192	0.0192	CcSEcCtD
Amisulpride—Embolism venous—Betamethasone—ankylosing spondylitis	0.0192	0.0192	CcSEcCtD
Amisulpride—Drug withdrawal syndrome—Prednisone—ankylosing spondylitis	0.0172	0.0172	CcSEcCtD
Amisulpride—Embolism venous—Prednisone—ankylosing spondylitis	0.0167	0.0167	CcSEcCtD
Amisulpride—Sudden death—Methotrexate—ankylosing spondylitis	0.0137	0.0137	CcSEcCtD
Amisulpride—Amenorrhoea—Methylprednisolone—ankylosing spondylitis	0.0121	0.0121	CcSEcCtD
Amisulpride—Deep vein thrombosis—Methotrexate—ankylosing spondylitis	0.0116	0.0116	CcSEcCtD
Amisulpride—Amenorrhoea—Dexamethasone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Amisulpride—Amenorrhoea—Betamethasone—ankylosing spondylitis	0.011	0.011	CcSEcCtD
Amisulpride—Endocrine disorder—Prednisone—ankylosing spondylitis	0.0102	0.0102	CcSEcCtD
Amisulpride—Amenorrhoea—Prednisone—ankylosing spondylitis	0.00958	0.00958	CcSEcCtD
Amisulpride—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.008	0.008	CcSEcCtD
Amisulpride—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.00735	0.00735	CcSEcCtD
Amisulpride—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.00734	0.00734	CcSEcCtD
Amisulpride—Sweating increased—Prednisolone—ankylosing spondylitis	0.00708	0.00708	CcSEcCtD
Amisulpride—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.00704	0.00704	CcSEcCtD
Amisulpride—Vaginal inflammation—Methotrexate—ankylosing spondylitis	0.00704	0.00704	CcSEcCtD
Amisulpride—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.00667	0.00667	CcSEcCtD
Amisulpride—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.00667	0.00667	CcSEcCtD
Amisulpride—Vaginal infection—Methotrexate—ankylosing spondylitis	0.00664	0.00664	CcSEcCtD
Amisulpride—Weight increased—Prednisolone—ankylosing spondylitis	0.00661	0.00661	CcSEcCtD
Amisulpride—Sweating increased—Triamcinolone—ankylosing spondylitis	0.00651	0.00651	CcSEcCtD
Amisulpride—Sweating increased—Methylprednisolone—ankylosing spondylitis	0.0065	0.0065	CcSEcCtD
Amisulpride—Neuropathy peripheral—Prednisolone—ankylosing spondylitis	0.00635	0.00635	CcSEcCtD
Amisulpride—Gynaecomastia—Methotrexate—ankylosing spondylitis	0.00629	0.00629	CcSEcCtD
Amisulpride—Weight increased—Triamcinolone—ankylosing spondylitis	0.00608	0.00608	CcSEcCtD
Amisulpride—Weight increased—Methylprednisolone—ankylosing spondylitis	0.00607	0.00607	CcSEcCtD
Amisulpride—Bradycardia—Prednisolone—ankylosing spondylitis	0.00592	0.00592	CcSEcCtD
Amisulpride—Sweating increased—Dexamethasone—ankylosing spondylitis	0.00591	0.00591	CcSEcCtD
Amisulpride—Sweating increased—Betamethasone—ankylosing spondylitis	0.00591	0.00591	CcSEcCtD
Amisulpride—Neuropathy peripheral—Triamcinolone—ankylosing spondylitis	0.00584	0.00584	CcSEcCtD
Amisulpride—Neuropathy peripheral—Methylprednisolone—ankylosing spondylitis	0.00583	0.00583	CcSEcCtD
Amisulpride—Cardiac arrest—Prednisone—ankylosing spondylitis	0.00581	0.00581	CcSEcCtD
Amisulpride—Weight increased—Betamethasone—ankylosing spondylitis	0.00552	0.00552	CcSEcCtD
Amisulpride—Weight increased—Dexamethasone—ankylosing spondylitis	0.00552	0.00552	CcSEcCtD
Amisulpride—Weight decreased—Betamethasone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Amisulpride—Weight decreased—Dexamethasone—ankylosing spondylitis	0.00549	0.00549	CcSEcCtD
Amisulpride—Hyperglycaemia—Betamethasone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Amisulpride—Hyperglycaemia—Dexamethasone—ankylosing spondylitis	0.00547	0.00547	CcSEcCtD
Amisulpride—Bradycardia—Triamcinolone—ankylosing spondylitis	0.00545	0.00545	CcSEcCtD
Amisulpride—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.00543	0.00543	CcSEcCtD
Amisulpride—Neuropathy peripheral—Betamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Amisulpride—Neuropathy peripheral—Dexamethasone—ankylosing spondylitis	0.0053	0.0053	CcSEcCtD
Amisulpride—Sweating increased—Prednisone—ankylosing spondylitis	0.00514	0.00514	CcSEcCtD
Amisulpride—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.00495	0.00495	CcSEcCtD
Amisulpride—Bradycardia—Betamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Amisulpride—Bradycardia—Dexamethasone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Amisulpride—Neutropenia—Prednisone—ankylosing spondylitis	0.00494	0.00494	CcSEcCtD
Amisulpride—Erectile dysfunction—Prednisone—ankylosing spondylitis	0.00486	0.00486	CcSEcCtD
Amisulpride—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.00484	0.00484	CcSEcCtD
Amisulpride—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.00482	0.00482	CcSEcCtD
Amisulpride—Weight increased—Prednisone—ankylosing spondylitis	0.00481	0.00481	CcSEcCtD
Amisulpride—Weight decreased—Prednisone—ankylosing spondylitis	0.00478	0.00478	CcSEcCtD
Amisulpride—Hyperglycaemia—Prednisone—ankylosing spondylitis	0.00476	0.00476	CcSEcCtD
Amisulpride—Depression—Prednisone—ankylosing spondylitis	0.0047	0.0047	CcSEcCtD
Amisulpride—Mental disorder—Methylprednisolone—ankylosing spondylitis	0.00468	0.00468	CcSEcCtD
Amisulpride—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00465	0.00465	CcSEcCtD
Amisulpride—Angioedema—Prednisolone—ankylosing spondylitis	0.00463	0.00463	CcSEcCtD
Amisulpride—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00462	0.00462	CcSEcCtD
Amisulpride—Angiopathy—Betamethasone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Amisulpride—Angiopathy—Dexamethasone—ankylosing spondylitis	0.0044	0.0044	CcSEcCtD
Amisulpride—Convulsion—Prednisolone—ankylosing spondylitis	0.00439	0.00439	CcSEcCtD
Amisulpride—Hypertension—Prednisolone—ankylosing spondylitis	0.00437	0.00437	CcSEcCtD
Amisulpride—Bradycardia—Prednisone—ankylosing spondylitis	0.0043	0.0043	CcSEcCtD
Amisulpride—Angioedema—Triamcinolone—ankylosing spondylitis	0.00426	0.00426	CcSEcCtD
Amisulpride—Angioedema—Methylprednisolone—ankylosing spondylitis	0.00425	0.00425	CcSEcCtD
Amisulpride—Neutropenia—Methotrexate—ankylosing spondylitis	0.00413	0.00413	CcSEcCtD
Amisulpride—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00406	0.00406	CcSEcCtD
Amisulpride—Convulsion—Triamcinolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Amisulpride—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00403	0.00403	CcSEcCtD
Amisulpride—Hypertension—Triamcinolone—ankylosing spondylitis	0.00402	0.00402	CcSEcCtD
Amisulpride—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00401	0.00401	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.004	0.004	CcSEcCtD
Amisulpride—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00394	0.00394	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00393	0.00393	CcSEcCtD
Amisulpride—Depression—Methotrexate—ankylosing spondylitis	0.00392	0.00392	CcSEcCtD
Amisulpride—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00388	0.00388	CcSEcCtD
Amisulpride—Angioedema—Betamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Amisulpride—Angioedema—Dexamethasone—ankylosing spondylitis	0.00386	0.00386	CcSEcCtD
Amisulpride—Angiopathy—Prednisone—ankylosing spondylitis	0.00384	0.00384	CcSEcCtD
Amisulpride—Immune system disorder—Prednisone—ankylosing spondylitis	0.00382	0.00382	CcSEcCtD
Amisulpride—Insomnia—Prednisolone—ankylosing spondylitis	0.00374	0.00374	CcSEcCtD
Amisulpride—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00372	0.00372	CcSEcCtD
Amisulpride—Mental disorder—Prednisone—ankylosing spondylitis	0.0037	0.0037	CcSEcCtD
Amisulpride—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Amisulpride—Malnutrition—Prednisone—ankylosing spondylitis	0.00368	0.00368	CcSEcCtD
Amisulpride—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Amisulpride—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Amisulpride—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00367	0.00367	CcSEcCtD
Amisulpride—Convulsion—Dexamethasone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Amisulpride—Convulsion—Betamethasone—ankylosing spondylitis	0.00366	0.00366	CcSEcCtD
Amisulpride—Hypertension—Dexamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Amisulpride—Hypertension—Betamethasone—ankylosing spondylitis	0.00365	0.00365	CcSEcCtD
Amisulpride—Anxiety—Dexamethasone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Amisulpride—Anxiety—Betamethasone—ankylosing spondylitis	0.00358	0.00358	CcSEcCtD
Amisulpride—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00354	0.00354	CcSEcCtD
Amisulpride—Insomnia—Triamcinolone—ankylosing spondylitis	0.00344	0.00344	CcSEcCtD
Amisulpride—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00343	0.00343	CcSEcCtD
Amisulpride—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Amisulpride—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Amisulpride—Agitation—Prednisone—ankylosing spondylitis	0.00338	0.00338	CcSEcCtD
Amisulpride—Angioedema—Prednisone—ankylosing spondylitis	0.00336	0.00336	CcSEcCtD
Amisulpride—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00335	0.00335	CcSEcCtD
Amisulpride—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00334	0.00334	CcSEcCtD
Amisulpride—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Amisulpride—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00333	0.00333	CcSEcCtD
Amisulpride—Urticaria—Prednisolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Amisulpride—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Amisulpride—Fatigue—Triamcinolone—ankylosing spondylitis	0.00328	0.00328	CcSEcCtD
Amisulpride—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00327	0.00327	CcSEcCtD
Amisulpride—Hypotension—Betamethasone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Amisulpride—Hypotension—Dexamethasone—ankylosing spondylitis	0.00322	0.00322	CcSEcCtD
Amisulpride—Angiopathy—Methotrexate—ankylosing spondylitis	0.00321	0.00321	CcSEcCtD
Amisulpride—Immune system disorder—Methotrexate—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Amisulpride—Convulsion—Prednisone—ankylosing spondylitis	0.00319	0.00319	CcSEcCtD
Amisulpride—Hypertension—Prednisone—ankylosing spondylitis	0.00318	0.00318	CcSEcCtD
Amisulpride—Anxiety—Prednisone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Amisulpride—Insomnia—Dexamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Amisulpride—Insomnia—Betamethasone—ankylosing spondylitis	0.00312	0.00312	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.00311	0.00311	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.0031	0.0031	CcSEcCtD
Amisulpride—Mental disorder—Methotrexate—ankylosing spondylitis	0.00309	0.00309	CcSEcCtD
Amisulpride—Malnutrition—Methotrexate—ankylosing spondylitis	0.00308	0.00308	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Amisulpride—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Amisulpride—Dyspepsia—Betamethasone—ankylosing spondylitis	0.00304	0.00304	CcSEcCtD
Amisulpride—Urticaria—Triamcinolone—ankylosing spondylitis	0.00302	0.00302	CcSEcCtD
Amisulpride—Urticaria—Methylprednisolone—ankylosing spondylitis	0.00301	0.00301	CcSEcCtD
Amisulpride—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.003	0.003	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.00298	0.00298	CcSEcCtD
Amisulpride—Fatigue—Betamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Amisulpride—Fatigue—Dexamethasone—ankylosing spondylitis	0.00297	0.00297	CcSEcCtD
Amisulpride—Nervous system disorder—Prednisone—ankylosing spondylitis	0.00295	0.00295	CcSEcCtD
Amisulpride—Skin disorder—Prednisone—ankylosing spondylitis	0.00292	0.00292	CcSEcCtD
Amisulpride—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.0029	0.0029	CcSEcCtD
Amisulpride—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Amisulpride—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.00282	0.00282	CcSEcCtD
Amisulpride—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.0028	0.0028	CcSEcCtD
Amisulpride—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.00279	0.00279	CcSEcCtD
Amisulpride—Leukopenia—Methotrexate—ankylosing spondylitis	0.00275	0.00275	CcSEcCtD
Amisulpride—Urticaria—Betamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Amisulpride—Urticaria—Dexamethasone—ankylosing spondylitis	0.00274	0.00274	CcSEcCtD
Amisulpride—Dizziness—Prednisolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Amisulpride—Asthenia—Triamcinolone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Amisulpride—Abdominal pain—Betamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Amisulpride—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.00273	0.00273	CcSEcCtD
Amisulpride—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Amisulpride—Insomnia—Prednisone—ankylosing spondylitis	0.00272	0.00272	CcSEcCtD
Amisulpride—Pruritus—Triamcinolone—ankylosing spondylitis	0.00269	0.00269	CcSEcCtD
Amisulpride—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00268	0.00268	CcSEcCtD
Amisulpride—Convulsion—Methotrexate—ankylosing spondylitis	0.00266	0.00266	CcSEcCtD
Amisulpride—Dyspepsia—Prednisone—ankylosing spondylitis	0.00264	0.00264	CcSEcCtD
Amisulpride—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.0026	0.0026	CcSEcCtD
Amisulpride—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Amisulpride—Fatigue—Prednisone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Amisulpride—Headache—Prednisolone—ankylosing spondylitis	0.00259	0.00259	CcSEcCtD
Amisulpride—Constipation—Prednisone—ankylosing spondylitis	0.00257	0.00257	CcSEcCtD
Amisulpride—Dizziness—Triamcinolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Amisulpride—Dizziness—Methylprednisolone—ankylosing spondylitis	0.00251	0.00251	CcSEcCtD
Amisulpride—Asthenia—Betamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Amisulpride—Asthenia—Dexamethasone—ankylosing spondylitis	0.00247	0.00247	CcSEcCtD
Amisulpride—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Amisulpride—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.00246	0.00246	CcSEcCtD
Amisulpride—Nausea—Prednisolone—ankylosing spondylitis	0.00245	0.00245	CcSEcCtD
Amisulpride—Pruritus—Dexamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Amisulpride—Pruritus—Betamethasone—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Amisulpride—Skin disorder—Methotrexate—ankylosing spondylitis	0.00244	0.00244	CcSEcCtD
Amisulpride—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.00243	0.00243	CcSEcCtD
Amisulpride—Vomiting—Triamcinolone—ankylosing spondylitis	0.00242	0.00242	CcSEcCtD
Amisulpride—Vomiting—Methylprednisolone—ankylosing spondylitis	0.00241	0.00241	CcSEcCtD
Amisulpride—Urticaria—Prednisone—ankylosing spondylitis	0.00239	0.00239	CcSEcCtD
Amisulpride—Headache—Triamcinolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Amisulpride—Headache—Methylprednisolone—ankylosing spondylitis	0.00238	0.00238	CcSEcCtD
Amisulpride—Abdominal pain—Prednisone—ankylosing spondylitis	0.00237	0.00237	CcSEcCtD
Amisulpride—Diarrhoea—Betamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Amisulpride—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.00236	0.00236	CcSEcCtD
Amisulpride—Hypotension—Methotrexate—ankylosing spondylitis	0.00235	0.00235	CcSEcCtD
Amisulpride—Dizziness—Betamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Amisulpride—Dizziness—Dexamethasone—ankylosing spondylitis	0.00228	0.00228	CcSEcCtD
Amisulpride—Insomnia—Methotrexate—ankylosing spondylitis	0.00227	0.00227	CcSEcCtD
Amisulpride—Nausea—Triamcinolone—ankylosing spondylitis	0.00226	0.00226	CcSEcCtD
Amisulpride—Nausea—Methylprednisolone—ankylosing spondylitis	0.00225	0.00225	CcSEcCtD
Amisulpride—Somnolence—Methotrexate—ankylosing spondylitis	0.00223	0.00223	CcSEcCtD
Amisulpride—Hypersensitivity—Prednisone—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Amisulpride—Dyspepsia—Methotrexate—ankylosing spondylitis	0.00221	0.00221	CcSEcCtD
Amisulpride—Vomiting—Betamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Amisulpride—Vomiting—Dexamethasone—ankylosing spondylitis	0.00219	0.00219	CcSEcCtD
Amisulpride—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.00217	0.00217	CcSEcCtD
Amisulpride—Fatigue—Methotrexate—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Amisulpride—Headache—Dexamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Amisulpride—Headache—Betamethasone—ankylosing spondylitis	0.00216	0.00216	CcSEcCtD
Amisulpride—Asthenia—Prednisone—ankylosing spondylitis	0.00215	0.00215	CcSEcCtD
Amisulpride—Pruritus—Prednisone—ankylosing spondylitis	0.00212	0.00212	CcSEcCtD
Amisulpride—Diarrhoea—Prednisone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Amisulpride—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Amisulpride—Nausea—Dexamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Amisulpride—Nausea—Betamethasone—ankylosing spondylitis	0.00205	0.00205	CcSEcCtD
Amisulpride—Urticaria—Methotrexate—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Amisulpride—Dizziness—Prednisone—ankylosing spondylitis	0.00199	0.00199	CcSEcCtD
Amisulpride—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00198	0.00198	CcSEcCtD
Amisulpride—Vomiting—Prednisone—ankylosing spondylitis	0.00191	0.00191	CcSEcCtD
Amisulpride—Headache—Prednisone—ankylosing spondylitis	0.00188	0.00188	CcSEcCtD
Amisulpride—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.00185	0.00185	CcSEcCtD
Amisulpride—Asthenia—Methotrexate—ankylosing spondylitis	0.0018	0.0018	CcSEcCtD
Amisulpride—Nausea—Prednisone—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Amisulpride—Pruritus—Methotrexate—ankylosing spondylitis	0.00178	0.00178	CcSEcCtD
Amisulpride—Diarrhoea—Methotrexate—ankylosing spondylitis	0.00172	0.00172	CcSEcCtD
Amisulpride—Dizziness—Methotrexate—ankylosing spondylitis	0.00166	0.00166	CcSEcCtD
Amisulpride—Vomiting—Methotrexate—ankylosing spondylitis	0.0016	0.0016	CcSEcCtD
Amisulpride—Headache—Methotrexate—ankylosing spondylitis	0.00157	0.00157	CcSEcCtD
Amisulpride—Nausea—Methotrexate—ankylosing spondylitis	0.00149	0.00149	CcSEcCtD
